资讯

Results After 6 hours, instillation of E. coli bacteria caused influx of inflammatory cells, which resulted in significant inflammation, lung protein permeability and pulmonary oedema formation.
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...
Additionally, while we observed increased P-selectin expression, elevated PLAs in HNSCC patients, and a potent reduction of P-selectin expression and PLA formation following 1,8-cineole treatment, the ...
Backed by findings from nearly three dozen workers with sarcoidosis who also reported occupational exposure to respirable crystalline silica (RCS), researchers have proposed a new term for the ...
IPF is a chronic disease that causes lung tissue to thicken and stiffen, leading to breathing difficulties. During a 12-week study of rentosertib, which enrolled 71 patients in China, Insilico ...
In doing so, it has also identified a way to reverse that damage and restore lung function. We already know that exposure to air pollution is bad for us , and it’s particularly damaging for our ...
Jobs related to black lung screening have been restored at the National Institute for Occupational Safety and Health, but questions remain about whether the federally required screening programs ...
Mark Brooke hopes the program will signal a new era of hope for lung cancer patients. (ABC News: Lucas Hill)The screening program will offer a bulk-billed low-dose CT scan for the 930,000 people ...
Pancreatic cancer spreads to liver or lung thanks to this protein. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 06 / 250603141156.htm ...
Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer (SCLC). The DLL3xCD3 bispecific has shown that it can help patients live ...
Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...